Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis

Microangiopathic hemolytic anemia (MAHA) is a rare subtype of hemolytic anemia characterized by elevated hemolytic markers and red blood cell destruction. Though uncommon, MAHA can occur as a complication of acute pancreatitis because of the associated inflammatory response. Patients with MAHA secon...

Full description

Saved in:
Bibliographic Details
Main Authors: Syedda Ayesha, Masood Muhammad Karim, Maria Ali, Abdul Hadi Shahid, Salman Naseem Adil
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2025-01-01
Series:The Korean Journal of Gastroenterology
Subjects:
Online Access:https://www.kjg.or.kr/journal/view.html?uid=6082&vmd=Full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206734112686080
author Syedda Ayesha
Masood Muhammad Karim
Maria Ali
Abdul Hadi Shahid
Salman Naseem Adil
author_facet Syedda Ayesha
Masood Muhammad Karim
Maria Ali
Abdul Hadi Shahid
Salman Naseem Adil
author_sort Syedda Ayesha
collection DOAJ
description Microangiopathic hemolytic anemia (MAHA) is a rare subtype of hemolytic anemia characterized by elevated hemolytic markers and red blood cell destruction. Though uncommon, MAHA can occur as a complication of acute pancreatitis because of the associated inflammatory response. Patients with MAHA secondary to pancreatitis show favorable outcomes when treated with plasma exchange. This paper presents the case of a patient diagnosed with acute pancreatitis-induced hemolytic anemia and thrombocytopenia, who was managed successfully with plasma exchange, steroids, and rituximab. Clinicians should maintain a high index of suspicion in patients with acute pancreatitis who present with anemia, thrombocytopenia, and schistocytes on peripheral smears, even in the absence of end-organ injuries and with normal ADAMTS13 activity. The early initiation of plasmapheresis can be lifesaving. The timely introduction of rituximab in cases where plasma exchange and steroids are insufficient, despite the ADAMTS13 activity status, may lead to better outcomes.
format Article
id doaj-art-9f1227ad3790499fbacd747ef054fdcb
institution Kabale University
issn 1598-9992
2233-6869
language English
publishDate 2025-01-01
publisher Jin Publishing & Printing Co.
record_format Article
series The Korean Journal of Gastroenterology
spelling doaj-art-9f1227ad3790499fbacd747ef054fdcb2025-02-07T06:28:30ZengJin Publishing & Printing Co.The Korean Journal of Gastroenterology1598-99922233-68692025-01-01851737710.4166/kjg.2024.110Microangiopathic Hemolytic Anemia: A Rare Complication of Acute PancreatitisSyedda Ayesha0https://orcid.org/0009-0007-4893-3335Masood Muhammad Karim1Maria Ali2Abdul Hadi Shahid3Salman Naseem Adil4Section of Gastroenterology, Department of Medicine, Aga Khan University, PakistanSection of Gastroenterology, Department of Medicine, Aga Khan University, PakistanSection of Haematology, Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, PakistanMedical college, Aga Khan University, Karachi, PakistanSection of Haematology, Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, PakistanMicroangiopathic hemolytic anemia (MAHA) is a rare subtype of hemolytic anemia characterized by elevated hemolytic markers and red blood cell destruction. Though uncommon, MAHA can occur as a complication of acute pancreatitis because of the associated inflammatory response. Patients with MAHA secondary to pancreatitis show favorable outcomes when treated with plasma exchange. This paper presents the case of a patient diagnosed with acute pancreatitis-induced hemolytic anemia and thrombocytopenia, who was managed successfully with plasma exchange, steroids, and rituximab. Clinicians should maintain a high index of suspicion in patients with acute pancreatitis who present with anemia, thrombocytopenia, and schistocytes on peripheral smears, even in the absence of end-organ injuries and with normal ADAMTS13 activity. The early initiation of plasmapheresis can be lifesaving. The timely introduction of rituximab in cases where plasma exchange and steroids are insufficient, despite the ADAMTS13 activity status, may lead to better outcomes.https://www.kjg.or.kr/journal/view.html?uid=6082&vmd=Fullpancreatitismicroangiopathic hemolytic anemiathrombocytopeniaplasmapheresisrituximab
spellingShingle Syedda Ayesha
Masood Muhammad Karim
Maria Ali
Abdul Hadi Shahid
Salman Naseem Adil
Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis
The Korean Journal of Gastroenterology
pancreatitis
microangiopathic hemolytic anemia
thrombocytopenia
plasmapheresis
rituximab
title Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis
title_full Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis
title_fullStr Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis
title_full_unstemmed Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis
title_short Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis
title_sort microangiopathic hemolytic anemia a rare complication of acute pancreatitis
topic pancreatitis
microangiopathic hemolytic anemia
thrombocytopenia
plasmapheresis
rituximab
url https://www.kjg.or.kr/journal/view.html?uid=6082&vmd=Full
work_keys_str_mv AT syeddaayesha microangiopathichemolyticanemiaararecomplicationofacutepancreatitis
AT masoodmuhammadkarim microangiopathichemolyticanemiaararecomplicationofacutepancreatitis
AT mariaali microangiopathichemolyticanemiaararecomplicationofacutepancreatitis
AT abdulhadishahid microangiopathichemolyticanemiaararecomplicationofacutepancreatitis
AT salmannaseemadil microangiopathichemolyticanemiaararecomplicationofacutepancreatitis